Eli Lilly and Company has significantly bolstered its position in the rapidly evolving cell and gene therapy (CGT) landscape with…
Read More

Eli Lilly and Company has significantly bolstered its position in the rapidly evolving cell and gene therapy (CGT) landscape with…
Read More
BRUSSELS, BELGIUM & SAN FRANCISCO, USA – April 20, 2026 – Global biopharmaceutical leader UCB has finalized a definitive agreement…
Read More
Acute Myelogenous Leukemia (AML) has long remained one of the most formidable challenges in oncology, characterized by its rapid progression…
Read More
Boehringer Ingelheim and Zai Lab have announced a significant clinical collaboration aimed at investigating a dual delta-like ligand 3 (DLL3)-targeting…
Read More
Amazon Web Services (AWS) has unveiled a groundbreaking artificial intelligence (AI) application designed to significantly accelerate the design and testing…
Read More
A landmark preclinical study has unveiled a novel gene therapy designed to neutralize chronic pain at its source within the…
Read More
A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…
Read More
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
In a landmark decision that reverberated through legal and advocacy circles, the U.S. Supreme Court ruled in late March that…
Read More
The global fight against cancer, a disease projected to claim over 10 million lives annually, continues to drive intense research…
Read More